Oxford BioTherapeutics
Edit Page
Report
Scan day: 04 March 2014 UTC
7
Virus safety - good
Description: OBT is developing innovative antibody-based cancer drugs, with integrated diagnostics, against novel targets that it has discovered in its unique OGAP proteomic database.
Our novel cancer therapies combine a number of precision technologies We are focused on developing antibody-drug conjugates to treat a range of cancers Our antibody-based therapeutics target a variety of difficult to treat cancers
Size: 230 chars
Contact Information
Email:Send Message
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Oxford BioTherapeutics |
| Keywords: | |
| Description: | |
| IP-address: | 213.246.102.235 |
WHOIS Info
| NS | Name servers: ns0.phase8.net ns1.phase8.net |
| WHOIS | |
| Date | Last updated: 09-Jul-2012 Expiry date: 21-Aug-2015 |